Judge Clears Alpharma's Generic Neurontin
Alpharma said Friday it was launching its Neurontin generic after hearings in the U.S. District Court for New Jersey ended without a ruling. Pfizer responded by launching its own generic capsules in the same 100 milligram, 300 milligram and 400 milligram doses as Alpharma.
U.S. District Court Judge John Liftland has scheduled hearings for mid-November for oral arguments...
To view the full article, register now.